Company Oncolytics Biotech Inc. Toronto S.E.
Equities
CA6823101077
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Kirk Look
DFI | Director of Finance/CFO | - | 01/03/01 |
Thomas Heineman
CTO | Chief Tech/Sci/R&D Officer | - | 01/20/01 |
Jon Patton
IRC | Investor Relations Contact | - | 01/20/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jonathan Rigby
BRD | Director/Board Member | 56 | 07/22/07 |
Patricia Andrews
BRD | Director/Board Member | 66 | 09/01 |
Bernd Seizinger
BRD | Director/Board Member | 67 | 08/15/08 |
James Parsons
BRD | Director/Board Member | 58 | 16/22/16 |
Angela Holtham
BRD | Director/Board Member | 73 | 18/14/18 |
Wayne Pisano
CEO | Chief Executive Officer | 69 | 09/13/09 |
Deborah Brown
BRD | Director/Board Member | - | 02/17/02 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 76,310,671 | 72,478,872 ( 94.98 %) | 0 | 94.98 % |
Company contact information
Oncolytics Biotech, Inc.
322–11th Avenue SW Suite 804
T2R 0C5, Calgary
+
http://www.oncolyticsbiotech.com![address Oncolytics Biotech Inc.](https://cdn.zonebourse.com/static/address/1411125.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+18.97% | 4.53TCr | |
+41.98% | 4.04TCr | |
-10.06% | 3.79TCr | |
+31.15% | 3.18TCr | |
-7.79% | 2.77TCr | |
+13.32% | 2.65TCr | |
+43.05% | 1.4TCr | |
+31.28% | 1.24TCr | |
-7.41% | 1.13TCr |